Company intelligence / Profile preview

Sichuan Jishengtang Pharmaceutical Co., Ltd.

Pengzhou, Sichuan, Chinadnb.com ↗

Ownership: Private
Employees: ~500
Development stage: Commercial

Overview

Sichuan Jishengtang Pharmaceutical has achieved regulatory approval in China for several products including Keluoxin Capsule for diabetes mellitus and ShuGanJieYuJiaoNang. Wujia Yizhi Granules are in Phase 3 development for Alzheimer's disease. The company focuses on both chemical medicines and traditional Chinese patent medicines with a track record of successful product approvals since at least May 2018.

Therapeutic areas: PsychiatryEndocrinologyNeurologyHematology
Modalities: Small moleculesTraditional patent medicine/TCMHerbal medicines
Industry: Biotech

Drug pipeline

5 assets

Keluoxin

4 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Sichuan Jishengtang Pharmaceutical Co., Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sichuan Jishengtang Pharmaceutical Co., Ltd..

Explore the full profile